Add Company
Join Now

Atrogi Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Atrogi's estimated annual revenue is currently $4.8M per year.(i)
  • Atrogi's estimated revenue per employee is $201,000

Employee Data

  • Atrogi has 24 Employees.(i)
  • Atrogi grew their employee count by -4% last year.

Atrogi's People

NameTitleEmail/Phone
1
Head Chemistry and IPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.3M10625%N/AN/A
#2
$61.7M3075%N/AN/A
#3
$15.1M75-12%N/AN/A
#4
$120.6M60022%N/AN/A
#5
$29.7M14821%N/AN/A
#6
$27.7M138-67%N/AN/A
#7
$31.2M15514%N/AN/A
#8
$25.3M12629%N/AN/A
#9
$108.7M54126%N/AN/A
#10
$1200M1397-6%$2.4BN/A
Add Company

What Is Atrogi?

Our vision is to market an state-of-the-art insulin-independent treatment to help T2D patients live a life free from diabetes symptoms and complications.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$4.8M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Atrogi News

2022-03-22 - BioRestorative Therapies Announces Research Collaboration ...

Professor Bengtsson is also co-founder of Atrogi and Sigrid Therapeutics, two clinical stage companies. Atrogi is developing a novel small...

2022-03-22 - Atrogi inleder fas 1-studie av ATR-258 mot typ 2-diabetes efter ...

ATR-258 är en helt ny klass av läkemedelsmolekyler för behandling av T2D och genom sin unika verkningsmekanism uppnås inte bara positiva...

2022-03-22 - Atrogi receives first regulatory approval from German health ...

This promotes glucose uptake in skeletal muscle resulting in a reduction of blood glucose levels achieved without insulin. Atrogi believes ATR-...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M24-56%N/A
#2
$3.4M24-35%N/A
#3
$2.4M24-4%N/A
#4
$4.5M244%N/A
#5
$3.8M24-14%N/A